Jennifer Sy - Aug 31, 2024 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role: PRINCIPAL ACCOUNTING OFFICER
Signature: /s/ Alexander Wilson as attorney-in-fact for Jennifer Sy
Stock symbol: AEON
Transactions as of: Aug 31, 2024
Transactions value $: $0
Form type: 4
Date filed: 9/4/2024, 09:53 PM
Previous filing: May 24, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AEON	Class A Common Stock	Award	$0	+18K		$0.00	18K	Aug 31, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AEON	Stock Option	Award	$0	+48.1K		$0.00	48.1K	Aug 31, 2024	Class A Common Stock	48.1K	$0.83	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of restricted stock units granted on August 31, 2024 (the "Grant Date"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.
F2	Represents an award of stock options granted on August 31, 2024 (the "Grant Date"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date.